Related to Gilead Grants New and Expanded Generics Licenses for HIV Drugs to Indian Firms

• Institute of Human Virology Awarded $23.4M to Fund Clinical Trials of HIV Vaccine
  
• Teva to Acquire Majority Stake in Japanese Generics Firm Taiyo for $460M
  
• Roche’s HIV Prognostic Test Gets Expanded European Clearance
  
• Roche’s Multivirus Blood-Screening Assay Achieves CE Mark
  
• Valeant to Buy Generics Firm Sanitas for $446M
  
• Watson Buys Generics Firm Specifar for $562 Million
  
• Epistem to Evaluate Xcelris' Genedrive PoC System for TB Diagnosis in India
  
• Roche to Provide HIV/AIDS Tests in South Africa for Early Infant Diagnosis
  
• Watson to Buy Generic Pharmaceuticals Related to Perrigo's Acquisition of Paddock
  
• Fujifilm and Dr. Reddy’s Ink Pact Covering Generic Drugs in Japan
  
• Studies Reveal that HIV-1 Can Mutate to Switch off Attack by Natural Killer Cells
  
• Gilead to Buy Biologics Facility in California from Genentech
  
• FDA Okays Gilead’s San Dimas, CA, Site for Continued Operation
  
• GeoVax Receives Latest Tranche of $19.6M NIAID Funding for HIV Vaccine
  
• Medivir Divests Generics Subsidiary for SEK 26M
  
• Horizon Licenses X-Man Panel for Viral Diseases and Leukemias from the University of Minnesota
  
• GeoVax Labs Receives $0.8M Funding Boost from NIAID to Progress HIV Vaccine
  
• Investigators Figure Out One Way to Stop HIV from Dampening Adaptive Immune Response
  
• Teva Acquires Kowa’s Half of Japanese Generics Joint Venture for $150M
  
• Evotec Takes Over Full Ownership of JV in India for €1.7M